Bcl xl inhibitory compounds having low cell permeability and antibody drug conjugates including the same

The present disclosure concerns Bcl-xL inhibitors having low cell permeability, antibody drug conjugates (ADCs) comprising the inhibitors, synthons useful for synthesizing the ADCs, compositions comprising the inhibitors or ADCs, and various methods of using the inhibitors and ADCs.

Saved in:
Bibliographic Details
Main Authors TAO Zhi-Fu, SHEN Xiaoqiang, SONG Xiaohong, BENNETT DAVID JONATHAN, DOHERTY George, WANG Xilu, ACKLER Scott L, WELCH Dennie S, MARIN Violeta L, WENDT Michael, FREY Robin R, SULLIVAN Gerard M, CULLEN Steve C, HAIGHT Anthony R, JUDD Andrew S, KUNZER Aaron, BOGHAERT Erwin R, SOUERS Andrew J
Format Patent
LanguageEnglish
Hebrew
Published 30.06.2021
Online AccessGet full text

Cover

More Information
Summary:The present disclosure concerns Bcl-xL inhibitors having low cell permeability, antibody drug conjugates (ADCs) comprising the inhibitors, synthons useful for synthesizing the ADCs, compositions comprising the inhibitors or ADCs, and various methods of using the inhibitors and ADCs.
Bibliography:Application Number: IL20210282594